Table 2.
Reason | N=64 |
---|---|
Patient Preference | 19 (30%) |
Biopsy Volume Progression | 15 (23%) |
Biopsy Grade Progression | 14 (22%) |
MRI Result | 9 (14%) |
Change in PSA Value or Digital Rectal Examination | 4 (6%) |
Prolaris Result (tissue-based biomarker) | 3 (5%) |
Abbreviation: MRI=magnetic resonance imaging, PSA=prostate-specific antigen